AE Patient Classification...................................................................................................................... 1
Airborne Spread................................................................................................................................. 1
Ancillary Services.............................................................................................................................. 29
Antibody/Antigen............................................................................................................................... 2
Behavioral Health............................................................................................................................. 27
Cleaning, Disinfecting Households and Facilities................................................................................... 9
Contact Tracing ................................................................................................................................ 38
Critical Resource Conservation.......................................................................................................... 12
Command and Control........................................................................................................................ 4
Communications ................................................................................................................................ 5
Contact Spread................................................................................................................................... 2
Crisis Standards of Care....................................................................................................................... 3
Definitions ......................................................................................................................................... 1
Documentation ................................................................................................................................. 6
Droplet Spread................................................................................................................................... 2
Environmental Services/Housekeeping.............................................................................................. 29
Executive Summary............................................................................................................................ 1
Facilities Management ....................................................................................................................... 8
Field Sanitation and Isolation............................................................................................................. 31
Ethical Considerations....................................................................................................................... 13
Human Resources............................................................................................................................. 18
Hygiene, Social Distancing, Shelter in Place, and General Protection Measures.................................... 17
Infection Prevention and Control (IPC)............................................................................................... 25
Intermediate Care Ward (ICW)............................................................................................................ 2
Laboratory (Screening/Testing) ......................................................................................................... 29
Medical Centers (MEDCENs), Contact Information.............................................................................. 26
Medical Management....................................................................................................................... 24
Mortuary Affairs............................................................................................................................... 28
Operational Planning ......................................................................................................................... 4
Pathogen.......................................................................................................................................... 29
Patient Under Investigation (PUI)........................................................................................................ 2
Performance Improvement ................................................................................................................ 6
Personal Protective Equipment (PPE) Considerations............................................................................ 8
Pharmacy......................................................................................................................................... 29
Quarantine Facilities......................................................................................................................... 10
Radiology......................................................................................................................................... 29
Resiliency/Well-Being....................................................................................................................... 27
Screening/Testing............................................................................................................................. 23
Skills Building/Training...................................................................................................................... 19
Staff (Patient: Staffing Ratios, Resilience/Well-Being).......................................................................... 18
Staff Surveillance and Staffing Decisions............................................................................................. 21
Supplies........................................................................................................................................... 33
Surge Capabilities............................................................................................................................. 11
Suspected, Confirmed Cases ............................................................................................................... 6
Telemedicine/VITAL-T/Points of Contact............................................................................................ 25
Transport........................................................................................................................................... 7
Triage/Security................................................................................................................................. 14